Fundraising Fox
NovoCure
NASDAQ: NVCRFounded 2000 · 1,504 employees on LinkedIn · 2 known investors
Find your way into NovoCure
Sign up to see every warm intro you have to NovoCure
- Paths you didn't know you had: your email and LinkedIn already hold routes to the NovoCure team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Novocure develops Tumor Treating Fields therapy for treating aggressive forms of cancer. The company focuses on patient-centered innovation in oncology.
Founders & leadership
NovoCure was founded in 2000 by Yoram Palti.
Investors · 2
Related companies · 2
Onkure Therapeutics IncOnKure Therapeutics is a clinical-stage biopharmaceutical company developing PI3Kα pan-mutant selective inhibitor medicines for the treatment of breast cancer and vascular anomalies. Its focus is on selective, allosteric small-molecule oncology therapeutics.
NextCureNextcure is a clinical-stage biopharmaceutical company developing immunotherapies targeting IO pathways, with a focus on oncology applications.
Companies working in the same space as NovoCure.
Frequently asked questions
- What does NovoCure do?
- Novocure develops Tumor Treating Fields therapy for treating aggressive forms of cancer. The company focuses on patient-centered innovation in oncology.
- Who founded NovoCure?
- NovoCure was founded by Yoram Palti in 2000.
- Who are NovoCure's investors?
- NovoCure's investors include Pfizer Venture Investments, Windham Capital Partners.